
Aya Shibuya, Ph.D.
Postdoctoral Fellow Inhibiting Nemo-like Kinase for Treatment of DBA

Minyoung Youn, Ph.D.
The Role of RSK in normal hematopoiesis and myeloid leukemogenesis

Naoki Horikoshi, Ph.D.
Postdoctoral Fellow (Wakatsuki Lab, SLAC and Bio-X), Development of CREB Inhibitors for treatment of Acute Leukemia

Mark Wilkes, Ph.D.
Instructor Normal and Aberrant Erythropoiesis

Mark Smith, Ph.D.
Medicinal Chemist, ChEM-H, Drug Development

Anna Wojcicki
Medical Student, University of Minnesota School of Medicine, Niclosamide for Treatment of AML

Ryan Sathianathen
Undergraduate Student, University of Pennsylvania, Regulation of p53 by Nemo-like Kinase

Kevin Jung
Undergraduate Student, Stanford University, Targeting Nemo-like Kinase in Diamond Blackfan Anemia

Kailen Mark
Life Science Research Professional, Mechanisms of drug resistance in AML

Mikhail Hameedi
Structural Biology of CREB:CBP and identification of inhibitors

Anika Dove
Administrative Assistant

Britney Erin Lee
Stanford undergraduate student, Nemo-like kinase and DBA